Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding 'Annual Report for the financial year ended March 31, 2026'. The company has sent the annual report and notice calling the 62nd Annual General Meeting (AGM) to members in electronic mode, and a physical letter with a link to the report was sent to shareholders whose email address is not updated.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Reporting (BRSR) for the financial year ended March 31, 2026'.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 08, 2026.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about the updated schedule of its 62nd Annual General Meeting (AGM) to be held on September 8, 2026, with a record date of September 1, 2026, for the purpose of AGM and payment of dividend.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has revised the record date to 01-Sep-2026 for the purpose of dividend.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Ltd. announced its financial results for the first quarter ended June 30, 2026, with sales of ₹ 901 crores, down by 5% versus year ago, and Profit After Tax (PAT) of ₹126 crores, impacted by commodity cost fluctuations due to geopolitical uncertainties.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about the 62nd Annual General Meeting (AGM) scheduled for September 2, 2026, with a record date of August 26, 2026, for the purpose of AGM and payment of dividend.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has revised the record date for dividend and AGM from August 17, 2026 to August 26, 2026.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has filed a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of securities on stock exchanges.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange about change in Senior Management Personnel, with Mr. Gopalakrishnan Kalianna appointed as Sales Head, effective August 1, 2026, and Ms. Rohini Venkateswaran elevated as Senior Vice President-Korea, also effective August 1, 2026.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Overseas India B.V., a promoter of Procter and Gamble Health Limited, has filed a disclosure under SEBI Takeover Regulations 31(4). The filing confirms its shareholding of 8,601,071 shares, amounting to 51.82% of Procter and Gamble Health Limited's paid-up capital. Furthermore, it declares that none of these shares were encumbered (pledged) as of March 31, 2026. This disclosure represents a routine compliance update.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited declared a final dividend of Rs. 60 per equity share for the financial year 2025-26, pending shareholder approval at the upcoming Annual General Meeting. The company also issued detailed communication regarding the deduction of Tax at Source (TDS) on this dividend income. It outlines the applicable TDS rates for resident and non-resident shareholders and specifies the necessary documentation, such as PAN and Form 121, to ensure proper tax compliance.

Procter & Gamble Hygiene and Health Care Limited

Procter & Gamble Hygiene and Health Care Limited has informed the exchanges about disclosures received under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. The company received intimations from Temple Trees Impex and Investment Pvt Ltd (TTIPL) and Procter & Gamble Home Products Private Limited (PGHPPL), both entities belonging to its promoter group. This announcement signifies a routine regulatory filing indicating that promoter group companies have undertaken transactions in the company's shares, triggering reporting obligations under insider trading rules. Investors should monitor subsequent detailed filings (Annexure 1, if provided) to understand the nature and scale of these promoter group transactions.